Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (21-30 of 418) with videos related to

Pageof 42
Sort By:
Mycoses|July 2, 2010
Case report 1: A case of failed posaconazole prophylaxisJohan Maertens, Kristof Cuppens, Hélène Schoemans
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2018
Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantationBarbara Deleenheer, Isabel Spriet, Johan Maertens
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatmentRosemary Barnes, Thomas Rogers, Johan Maertens
Journal of Clinical Microbiology|January 15, 2016
Pretreatment of Bronchoalveolar Lavage Fluid Samples with SLsolution Leads to False-Negative Aspergillus Galactomannan LevelsSarah Gils, Johan Maertens, Katrien Lagrou
The New England Journal of Medicine|April 25, 2019
Ibrutinib Regimens in Older Patients with Untreated CLLToine Mercier, Ann Janssens, Johan Maertens
Transplantation Reviews (Orlando, Fla.)|December 24, 2018
Fungal infections in solid organ transplantation: An update on diagnosis and treatmentVincent Kabir, Johan Maertens, Dirk Kuypers
Current Infectious Disease Reports|October 24, 2008
Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patientsJohan Maertens, Griet Huysmans, Koen Theunissen
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspectiveKatrien Lagrou, Rafael F Duarte, Johan Maertens
Current Opinion in Infectious Diseases|March 12, 2009
New therapies for fungal pneumoniaJohan Maertens, Wouter Meersseman, Pascal Van Bleyenbergh
The New England Journal of Medicine|March 8, 2018
Letermovir Prophylaxis for CytomegalovirusFrancisco M Marty, Johan Maertens, Cyrus Badshah
Pageof 42

Showing results (21-30 of 418) with videos related to

Sort By:
Pageof 42
Mycoses|July 2, 2010
Case report 1: A case of failed posaconazole prophylaxisJohan Maertens, Kristof Cuppens, Hélène Schoemans
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2018
Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantationBarbara Deleenheer, Isabel Spriet, Johan Maertens
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatmentRosemary Barnes, Thomas Rogers, Johan Maertens
Journal of Clinical Microbiology|January 15, 2016
Pretreatment of Bronchoalveolar Lavage Fluid Samples with SLsolution Leads to False-Negative Aspergillus Galactomannan LevelsSarah Gils, Johan Maertens, Katrien Lagrou
The New England Journal of Medicine|April 25, 2019
Ibrutinib Regimens in Older Patients with Untreated CLLToine Mercier, Ann Janssens, Johan Maertens
Transplantation Reviews (Orlando, Fla.)|December 24, 2018
Fungal infections in solid organ transplantation: An update on diagnosis and treatmentVincent Kabir, Johan Maertens, Dirk Kuypers
Current Infectious Disease Reports|October 24, 2008
Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patientsJohan Maertens, Griet Huysmans, Koen Theunissen
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspectiveKatrien Lagrou, Rafael F Duarte, Johan Maertens
Current Opinion in Infectious Diseases|March 12, 2009
New therapies for fungal pneumoniaJohan Maertens, Wouter Meersseman, Pascal Van Bleyenbergh
The New England Journal of Medicine|March 8, 2018
Letermovir Prophylaxis for CytomegalovirusFrancisco M Marty, Johan Maertens, Cyrus Badshah
Pageof 42